Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Nimble Therapeutics Spins Out from Roche to Commercialize Novel Drug Discovery Technology with Financing from Telegraph Hill Partners 2019-04-30 22:00
Australia's First Commercial MGISEQ-2000 Genetic Sequencer Now in Operation 2019-04-30 21:30
EirGenix, Inc. Enters Into Global License Agreement for the Commercialization of its Biosimilar Drug EG12014 2019-04-30 08:20
Bumrungrad Hospital raises the bar of innovative cancer treatment with comprehensive genomic testing in Thailand 2019-04-29 15:13
China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Derazantinib 2019-04-29 09:00
Frost & Sullivan: Pharmaceutical and Biotech Sectors to Drive Investments in the Asia-Pacific Healthcare Industry 2019-04-25 17:14
Innovent Announces First Patient Dosed in Phase I Clinical Trial of IBI318 Bispecific Antibody in China 2019-04-24 07:21
Gracell Bio Announces FasT CAR-T, a Breakthrough Technology for Hematological Malignancies 2019-04-23 17:08
Circle DNA launches Next Generation Consumer Genetic Test 2019-04-22 23:42
TAU BIO-LOGIC Announces Humanization of Picomolar Affinity Monoclonal Antibody Targeting TauC3 Protein for the Treatment of Alzheimer's Disease and Progressive Supranuclear Palsy 2019-04-18 21:30
Zuellig Pharma, NICVB and NIHE announce project to expand access to vaccines in Vietnam through the use of innovative eZCooler technology 2019-04-18 18:36
China based innovation, CDMOs and Parallel Approvals driving huge growth in manufacturing at CPhI China 2019-04-18 15:00
Innovent Announces First Patient Dosed in a Phase I Clinical Trial of IBI302 for the Treatment of Wet AMD 2019-04-18 08:10
Ping An Wins Three Championships at ISBI with its AI Image Technologies 2019-04-17 18:43
Financial year 2018: Boehringer Ingelheim grows and invests 2019-04-17 16:30
WuXi Biologics Successfully Completed First FDA Routine GMP Inspection 2019-04-17 09:14
I-Mab Biopharma and WuXi Biologics Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs 2019-04-16 20:39
BioAtla Subsidiary, Himalaya Therapeutics, Will Develop And Commercialize CAB Products In Greater China Market 2019-04-16 06:00
Anpac Bio CDA Liquid Biopsy Technology Selected by FAST COMPANY 2019 "WORLD CHANGING IDEAS AWARD" 2019-04-11 21:45
I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris and a Boston-Based, Leading Academic Medical Center 2019-04-08 09:01
1 179 180 181 182 183 224